George MA - Search Results

1

Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model.

Abelson MB, George MA, Smith LM. Abelson MB, et al. Among authors: george ma. Ophthalmology. 1995 Feb;102(2):310-6. doi: 10.1016/s0161-6420(95)31023-8. Ophthalmology. 1995. PMID: 7862419 Clinical Trial.

2

Allergic conjunctivitis: a survey of new antihistamines.

Berdy GJ, Abelson MB, George MA, Smith LM, Giovanoni RL. Berdy GJ, et al. Among authors: george ma. J Ocul Pharmacol. 1991 Winter;7(4):313-24. doi: 10.1089/jop.1991.7.313. J Ocul Pharmacol. 1991. PMID: 1687324 Clinical Trial.

3

Effects of Vasocon-A in the allergen challenge model of acute allergic conjunctivitis.

Abelson MB, Paradis A, George MA, Smith LM, Maguire L, Burns R. Abelson MB, et al. Among authors: george ma. Arch Ophthalmol. 1990 Apr;108(4):520-4. doi: 10.1001/archopht.1990.01070060068051. Arch Ophthalmol. 1990. PMID: 2322153 Clinical Trial.

4

Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitis.

Abelson MB, George MA, Schaefer K, Smith LM. Abelson MB, et al. Among authors: george ma. J Allergy Clin Immunol. 1994 Sep;94(3 Pt 1):458-64. doi: 10.1016/0091-6749(94)90201-1. J Allergy Clin Immunol. 1994. PMID: 7916020 Clinical Trial.

5

Histaminase activity in patients with vernal keratoconjunctivitis.

Abelson MB, Leonardi AA, Smith LM, Fregona IA, George MA, Secchi AG. Abelson MB, et al. Among authors: george ma. Ophthalmology. 1995 Dec;102(12):1958-63. doi: 10.1016/s0161-6420(95)30768-3. Ophthalmology. 1995. PMID: 9098303

6

Alteration of mucin in human conjunctival epithelia in dry eye.

Danjo Y, Watanabe H, Tisdale AS, George M, Tsumura T, Abelson MB, Gipson IK. Danjo Y, et al. Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2602-9. Invest Ophthalmol Vis Sci. 1998. PMID: 9856770

7

The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate.

Abelson M, Howes J, George M. Abelson M, et al. J Ocul Pharmacol Ther. 1998 Dec;14(6):533-42. doi: 10.1089/jop.1998.14.533. J Ocul Pharmacol Ther. 1998. PMID: 9867336 Clinical Trial.

8

Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects.

Berdy GJ, Abelson MB, Smith LM, George MA. Berdy GJ, et al. Among authors: george ma. Arch Ophthalmol. 1992 Apr;110(4):528-32. doi: 10.1001/archopht.1992.01080160106043. Arch Ophthalmol. 1992. PMID: 1562263

9

A scanning electron micrographic comparison of the effects of two preservative-free artificial tear solutions on the corneal epithelium as compared to a phosphate buffered saline and a 0.02% benzalkonium chloride control.

Schaefer K, George MA, Abelson MB, Garofalo C. Schaefer K, et al. Among authors: george ma. Adv Exp Med Biol. 1994;350:459-64. doi: 10.1007/978-1-4615-2417-5_79. Adv Exp Med Biol. 1994. PMID: 8030519 No abstract available.

10

A precise method of using rose bengal in the evaluation of dry eye and the detection of changes in its severity.

George MA, Abelson MB, Schaefer K, Mooshian M, Weintraub D. George MA, et al. Adv Exp Med Biol. 1994;350:549-52. doi: 10.1007/978-1-4615-2417-5_93. Adv Exp Med Biol. 1994. PMID: 7518185 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters